Immune Responses: Adverse Versus Non-Adverse Effects

Abstract

The adaptive immune system in vertebrates has evolved to provide host resistance to infectious microorganisms and malignant disease. Normal immune function and the induction of specific immune responses require the orchestrated interaction between cells and molecules both within and outside the lymphoid system. Immunotoxicology can be defined as the study of adverse health effects that may result from the interaction of xenobiotics with the immune system. In general terms such effects can take one of two forms. The first of these is immunotoxicity (or immunosuppression) where there is a perturbation of, or damage to, one or more components of the immune system resulting in impaired immune function and reduced host resistance. The design and interpretation of experimental immunotoxicity studies and the investigation of clinical immunosuppression require consideration of the relationship between changes in the structure and/or function of discrete components of the immune system and holistic changes in the susceptibility to infectious and malignant disease. The other main way in which chemicals may cause adverse health effects secondary to interaction with the immune system is through stimulation of specific immune responses that result in allergic disease. Allergy to chemicals and proteins can take many forms, including allergic contact dermatitis, allergic sensitization of the respiratory tract (associated with rhinitis and/or asthma), systemic allergic reactions (associated frequently with drug treatment), and gastrointestinal disease. Here there is a need to distinguish between immunogenic responses per se and those immune responses that are of sufficient vigor and of the quality necessary to provoke allergic sensitization. The purpose of this article is to explore the extent to which distinctions can be drawn between adverse and nonadverse effects in the context of immunotoxicity and allergy.

Keywords

Immunotoxicology allergy immunotoxicity testing skin sensitization respiratory sensitization adverse effects nonadverse effects.

References

Basketter DA , Bremmer JN , Buckley P. , Kammuller ME , Kawabata T. , Kimber I. , Loveless SE , Magda S. , Stringer DA , Vohr H-W. (1995). Pathology considerations for, and subsequent risk assessment of, chemicals identifi ed as immunosuppressive in routine toxicology. Fd Chem Toxic 33: 239—243.

Basketter DA , Gerberick GF , Kimber I. (1998). Strategies for identifying false positive responses in predictive skin sensitization tests. Fd Chem Toxic 36: 327—333.

Basketter DA , Lea LJ , Cooper K. , Stocks J. , Dickens A. , Pate I. , Dearman RJ , Kimber I. (1999). Threshold for classifi cation as a skin sensitizer in the local lymph node assay: A statistical evaluation . Fd Chem Toxic 37: 1167—1174.

Cumberbatch M. , Scott RC , Basketter DA , Scholes EW , Hilton J. , Dearman RJ , Kimber I. (1993). Infl uence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induce d lymph node activation . Toxicology 77: 181—191.

Dearman RJ , Basketter DA , Kimber I. (1999). Local lymph node assay: Use in hazard and risk assessment. J Appl Toxicol 19: 299—306.

Friedmann PS (1990). The immunology of allergic contact dermatitis: The DNCB story. Adv Dermatol 5: 175—196.

Friedmann PS , Rees J. , White SI , Matthews JN (1990). Low-dose exposure to antigen induces sub-clinical sensitization. Clin Exp Immunol 81: 507— 509.

Immunotoxicology Technical Committee, ILSI Health and Environmental Sciences Institute (1995). Immunotoxicity testing and risk assessment: Summary of a 1994 workshop . Fd Chem Toxic 33: 887—894.

Kimber I. , Basketter DA (1997). Contact sensitization: A new approach to risk assessment. Human Ecol Risk Assess 3: 553—560.

10.

Kimber I. , Dearman RJ (1991). Investigation of lymph node cell proliferation as a possible immunological correlate of contact sensitizing potential. Fd Chem Toxic 29: 125—129.

11.

Kimber I. , Dearman RJ (1997). Cell and molecular biology of chemical allergy . Clin Rev Allergy Immunol 15: 145 —168.

12.

Kimber I. , Dearman RJ (1999). Mechanisms of sensitization to chemical allergens . Comments Toxicol 7: 9—30.

13.

Luster MI , Kimber I. (1996). Immunotoxicity: Hazard identifi cation and risk assessment. Human Exp Toxicol 15: 947—948.

14.

Luster MI , Portier C. , Pait DG , Rosenthal GJ , Germolec DR , Corsini E. , Blaylock BL , Pollock P. , Kouchi Y. , Criag W. , White KL , Munson AE , Comment CE (1993). Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol 21: 71—82.

15.

Luster MI , Portier C. , Pait DG , White KL Jr , Gennings C. , Munson AE , Rosenthal GJ (1992). Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18: 200—210.

16.

Rycroft RJG , Menne T. , Frosch PJ , Lepoittevin J-P. (2001). Textbook of Contact Dermatitis. 3rd ed, Springer, Berlin .

17.

Schuurman HJ , Kuper CF , Vos JG (1994). Histopathology of the immune system as a tool to assess immunotoxicity. Toxicology 86: 187—212.

18.

Schuurman HJ , Van Loveren H. , Rozing J. , Vos JG (1992). Chemicals trophic for the thymus: Risk for immunodeficiency and autoimmunity . Int J Immunopharmac 17: 369—375.

19.

Selgrade MK (1999). Use of immunotoxicity data inhealthrisk assessments: Uncertainties and research to improve the process . Toxicology 133: 59—72.

20.

The ICICIS Group Investigators (1998). Report of a validation study of assessment of direct immunotoxicity in the rat. Toxicology 125: 183—201.

21.

Trizio D. , Basketter DA , Botham PA , Graepel PH , Lambre C. , Magda SJ , Pal TM , Riley AJ , Ronneberger H. , Van Sittert NJ , Bontinek WJ (1988). Identifi cation of immunotoxic effects of chemicals and assessment of their relevance to man. Fd Chem Toxic 26: 527—539.